Avraham Gabay insider trades

Open-market stock purchases and sales by Avraham Gabay, Chief Financial Officer at Oramed Pharmaceuticals Inc, from SEC Form 4 filings since Jun 17, 2019.

Recent trades

DateStockTradeValue
Oct 1, 2026ORMP Oramed Pharmaceuticals IncSold$90.2K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Aug 20, 2026LFWD Lifeward LtdBought (not open market)—
Jul 1, 2026ORMP Oramed Pharmaceuticals IncSold$331K
Mar 17, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Jan 22, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—

Companies traded

  • ORMP Oramed Pharmaceuticals Inc: 2 sales, last Oct 1, 2026
  • LFWD Lifeward Ltd: other filings, last Aug 20, 2026

Get free alerts when Avraham Gabay files a new trade →